Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam for terminal agitation in palliative care patients
DRKS00026775Phase 2Completed
- Sponsor
- Universität Heidelberg Seminarstraße
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of midazolam in terminal agitation (2 arms), sponsored by Universität Heidelberg Seminarstraße. Started Jul 2022; status: completed.
02
Drugs
midazolam
03
Conditions
terminal agitation
Beyond the preview
Go deeper on DRKS00026775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00026775.